Alkem Laboratories Limited has informed the Exchange about increase in investment to be made for setting up of manufacturing facility of the Company in Ujjain, Madhya Pradesh.
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Alkem Laboratories has informed the exchanges that its Board has approved increasing the investment for its upcoming greenfield formulations manufacturing facility in Ujjain, Madhya Pradesh. The capex has been raised from the earlier approved amount of up to INR 533 crores to up to INR 1036 crores, nearly doubling the planned outlay. The investment will be made in a phased manner on the 30-acre land parcel allotted by DMIC Vikram Udyogpuri Limited. This follows the company's earlier intimation dated 18th March 2026 regarding the land allotment and initial approval. The disclosure has been made under SEBI LODR Regulation 30.
The near-doubling of capex signals a larger or more technologically advanced facility than initially planned, which could boost long-term manufacturing capacity and future growth. In the short term, the higher capital commitment may put some pressure on cash flows and is worth tracking for execution timelines and returns.